Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/28/25 19:51 | 10/28/25 | VKTX | Health | Drug | Pharmaceutical Preparations | Mancini Marianna | CA | O | COO | 4 | S.d | -3,682 | 44.53 | 0 | -83 | 382 | D | |||||||||||||||
10/28/25 19:49 | 10/27/25 | VKTX | Health | Drug | Pharmaceutical Preparations | Rowland Charles A Jr | CA | D | 1 | S.d | -2,134 | 35.57 | 0 | -60 | 30 | D | ||||||||||||||||
10/28/25 19:48 | 10/28/25 | VKTX | Health | Drug | Pharmaceutical Preparations | Lian Brian | CA | DO | P,CEO | 7 | S.d | -39,902 | 56.50 | 0 | -706 | 2,419 | D | |||||||||||||||
10/28/25 19:47 | 10/28/25 | VKTX | Health | Drug | Pharmaceutical Preparations | Zante Greg | CA | O | CFO | 5 | S.d | -13,497 | 64.71 | 0 | -209 | 187 | D | |||||||||||||||
11/8/24 18:22 | 11/8/24 | VKTX | Health | Drug | Pharmaceutical Preparations | Macartney Lawson | CA | D | 1 | S.d | -137 | 68.67 | 0 | -2 | 48 | D | ||||||||||||||||
10/25/24 19:28 | 10/25/24 | VKTX | Health | Drug | Pharmaceutical Preparations | Rouan Sarah Kathryn | CA | D | 1 | S.d | -890 | 80.89 | 0 | -11 | -100 | 0 | D | |||||||||||||||
10/25/24 19:27 | 10/25/24 | VKTX | Health | Drug | Pharmaceutical Preparations | Singleton J Matthew | CA | D | 5 | S.d | -4,576 | 66.53 | 0 | -69 | 10 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |